search
Back to results

Artificial Intelligence Assists Surgeons' Decision Making

Primary Purpose

Rectal Cancer

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Artificial intelligence algorithm
Sponsored by
Jichao Qin
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Rectal Cancer focused on measuring artificial intelligence,, rectal cancer, temporary ileostomy, anastomotic leakage

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Aged older than 18 years and younger than 85 years.
  2. Primary rectal adenocarcinoma confirmed by preoperative pathology result.
  3. Expected curative resection via total mesorectal excision procedure.
  4. American Society of Anesthesiologists (ASA) class I, II, or III.
  5. Written informed consent.

Exclusion Criteria:

  1. Pregnant or breastfeeding women.
  2. Severe mental disorder or language communication disorder.
  3. Hartmann surgery or colostomy is performed intraoperatively.
  4. Interrupted of surgery for more than 30 minutes due to any cause.
  5. Malignant tumors with other organs

Sites / Locations

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control

Intervention

Arm Description

Whether the patients in the control arm will receive a temporary ileostomy depends on surgeons' experience.

Whether the patients in the intervention arm will receive a temporary ileostomy depends on the risk of anastomotic leakage calculated by the artificial intelligence algorithm.

Outcomes

Primary Outcome Measures

The rate of temporary ileostomy.
The morbidity of anastomotic leakage.
The diagnosis of anastomotic leakage is determined when the passage of fecal material from pelvic drainage tube or the water-soluble contrast agent enema and extra-rectal imaging. Alternatively, anastomotic leakage can be diagnosed when the integrity of the anastomosis is interrupted or the appearance of pelvic abscess next to the anastomosis by computerized tomography (CT) examination or secondary surgical exploration.

Secondary Outcome Measures

Full Information

First Posted
August 8, 2021
Last Updated
January 7, 2023
Sponsor
Jichao Qin
search

1. Study Identification

Unique Protocol Identification Number
NCT04999007
Brief Title
Artificial Intelligence Assists Surgeons' Decision Making
Official Title
Artificial Intelligence-assisted Decision Making for Temporary Ileostomy: A Prospective Randomized Controlled Trail.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 2, 2021 (Actual)
Primary Completion Date
September 2024 (Anticipated)
Study Completion Date
October 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Jichao Qin

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This study will evaluate whether artificial intelligence technique reduces the temporary ileostomy rate in patients with rectal cancer who receive anterior resection.
Detailed Description
Anastomotic leakage is a serious and life-threatening complication after anterior resection in patients with rectal cancer, and temporary ileostomy was introduced to reduce the serious consequences due to anastomotic leakage. However, whether a temporary ileostomy is applied in the surgery depends on the surgeon's experience, and there are no clinical guidelines to follow. Recently, artificial intelligence has widely been applied in medical field and produced some exciting results, and we have developed a high-performance artificial intelligence model based on 2369 rectal cancer patients, which showed good discrimination of anastomotic leakage and may reduce the temporary ileostomy rate. Hence, this randomized controlled trail will evaluate the artificial intelligence model for guiding surgical decision-making of performing a temporary ileostomy in patients with rectal cancer who receive anterior resection.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rectal Cancer
Keywords
artificial intelligence,, rectal cancer, temporary ileostomy, anastomotic leakage

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
616 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
Whether the patients in the control arm will receive a temporary ileostomy depends on surgeons' experience.
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Whether the patients in the intervention arm will receive a temporary ileostomy depends on the risk of anastomotic leakage calculated by the artificial intelligence algorithm.
Intervention Type
Other
Intervention Name(s)
Artificial intelligence algorithm
Intervention Description
Temporary ileostomy will be performed in the patients with high-risk of anastomotic leakage and not performed in the patients with low-risk of anastomotic leakage.
Primary Outcome Measure Information:
Title
The rate of temporary ileostomy.
Time Frame
Intraoperative period
Title
The morbidity of anastomotic leakage.
Description
The diagnosis of anastomotic leakage is determined when the passage of fecal material from pelvic drainage tube or the water-soluble contrast agent enema and extra-rectal imaging. Alternatively, anastomotic leakage can be diagnosed when the integrity of the anastomosis is interrupted or the appearance of pelvic abscess next to the anastomosis by computerized tomography (CT) examination or secondary surgical exploration.
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged older than 18 years and younger than 85 years. Primary rectal adenocarcinoma confirmed by preoperative pathology result. Expected curative resection via total mesorectal excision procedure. American Society of Anesthesiologists (ASA) class I, II, or III. Written informed consent. Exclusion Criteria: Pregnant or breastfeeding women. Severe mental disorder or language communication disorder. Hartmann surgery or colostomy is performed intraoperatively. Interrupted of surgery for more than 30 minutes due to any cause. Malignant tumors with other organs
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jichao Qin, MD
Phone
+86-27-83665316
Email
jcqin@tjh.tjmu.edu.cn
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jichao Qin, MD
Organizational Affiliation
Huazhong University of Science and Technology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
City
Wuhan
State/Province
Hubei
ZIP/Postal Code
430000
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jichao Qin, MD
Phone
+86-27-69378479

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Artificial Intelligence Assists Surgeons' Decision Making

We'll reach out to this number within 24 hrs